“Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer”

ROS1 fusion is an infrequent, but attractive target for therapy in patients with metastatic non- small-cell lung cancer. In studies on mainly late-stage disease, the prevalence of ROS1 fusions is about 1 –3%. I...

Source: Diagnostic Pathology - May 27, 2023 Category: Pathology Authors: Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, P ål Suhrke, Marianne Odnakk Ludahl, Joakim Oliu Moe, Inger Johanne Zwicky Eide, Marius Lund-Iversen and Odd Terje Brustugun Tags: Research Source Type: research